The cardiac transplant donor: identification, assessment, and management
AB Van Bakel - The American journal of the medical sciences, 1997 - Elsevier
In the previous 2 decades, there have been many advances in the treatment of coronary and
valvular heart disease. However, these treatments remain imperfect, and more patients are …
valvular heart disease. However, these treatments remain imperfect, and more patients are …
[引用][C] The cardiac transplant donor: identification, assessment, and management: Heart transplantation symposium
AB VAN BAKEL - The American journal of the medical …, 1997 - pascal-francis.inist.fr
The cardiac transplant donor : identification, assessment, and management : Heart
transplantation symposium CNRS Inist Pascal-Francis CNRS Pascal and Francis …
transplantation symposium CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[引用][C] The Cardiac Transplant Donor: Identification, Assessment, and Management
AB Van Bakel - American Journal of the Medical …, 1997 - repository.library.georgetown.edu
The Cardiac Transplant Donor: Identification, Assessment, and Management Toggle
navigation Georgetown University Logo Georgetown University Library Logo …
navigation Georgetown University Logo Georgetown University Library Logo …
The cardiac transplant donor: identification, assessment, and management
AB Van Bakel - The American journal of the medical …, 1997 - pubmed.ncbi.nlm.nih.gov
In the previous 2 decades, there have been many advances in the treatment of coronary and
valvular heart disease. However, these treatments remain imperfect, and more patients are …
valvular heart disease. However, these treatments remain imperfect, and more patients are …
The cardiac transplant donor: identification, assessment, and management.
AB Van Bakel - The American Journal of the Medical Sciences, 1997 - europepmc.org
In the previous 2 decades, there have been many advances in the treatment of coronary and
valvular heart disease. However, these treatments remain imperfect, and more patients are …
valvular heart disease. However, these treatments remain imperfect, and more patients are …